Search

Your search keyword '"A. Katus Hugo"' showing total 4,376 results
Start Over Author "A. Katus Hugo"
4,376 results on '"A. Katus Hugo"'

52. Insulin resistance in Takotsubo syndrome.

Author

Bruns, Bastian, Joos, Maximilian, Elsous, Nesrin, Katus, Hugo A., Schultz, Jobst‐Hendrik, Frey, Norbert, Backs, Johannes, and Meder, Benjamin

Subjects
MYOCARDIAL infarction, BLOOD sugar, MANN Whitney U Test, INSULIN therapy, VENTRICULAR ejection fraction, INSULIN resistance
Abstract

Aims: Takotsubo syndrome (TTS) is an acute heart failure (AHF) syndrome mimicking the symptoms of acute myocardial infarction. Impaired outcome has been shown, making risk stratification and novel therapeutic concepts a necessity. We hypothesized insulin resistance with elevated plasma glucose and potentially myocardial glucose deprivation to contribute to the pathogenesis of TTS and investigated the therapeutic benefit of insulin in vivo. Methods and results: First, we retrospectively analysed patient data of n = 265 TTS cases (85.7% female, mean age 71.1 ± 14.1 years) with documented initial plasma glucose from the Department of Cardiology of the University Hospital Heidelberg in Germany (May 2011 to May 2021). Median split of the study population according to glucose levels (≤123 mg/dL vs. >123 mg/dL) yielded significantly elevated mean heart rate (80.75 ± 18.96 vs. 90.01 ± 22.19 b.p.m., P < 0.001), left ventricular end‐diastolic pressure (LVEDP, 18.51 ± 8.35 vs. 23.09 ± 7.97 mmHg, P < 0.001), C‐reactive protein (26.14 ± 43.30 vs. 46.4 ± 68.6 mg/L, P = 0.006), leukocyte count (10.12 ± 4.29 vs. 15.05 ± 9.83/nL, P < 0.001), peak high‐sensitive Troponin T (hs‐TnT, 515.44 ± 672.15 vs. 711.40 ± 736.37 pg/mL, P = 0.005), reduced left ventricular ejection fraction (EF, 34.92 ± 8.94 vs. 31.35 ± 8.06%, P < 0.001), and elevated intrahospital mortality (2.3% vs. 12.1%, P = 0.002) in the high‐glucose group (Student's t‐test, Mann–Whitney U test, or chi‐squared test). Linear regression indicated a significant association of glucose with HR (P < 0.001), LVEDP (P = 0.014), hs‐TnT kinetics from admission to the next day (P < 0.001), hs‐TnT the day after admission (P < 0.001), as well as peak hsTnT (P < 0.001). Logistic regression revealed significant association of glucose with a composite intrahospital outcome including catecholamine use, respiratory support, and resuscitation [OR 1.010 (1.004–1.015), P = 0.001]. To further investigate the potential role of glucose in TTS pathophysiology experimentally, we utilized an in vivo murine model of epinephrine (EPI)‐driven reversible AHF. For this, male mice underwent therapeutic injection of insulin (INS, 1 IU/kg) or/and glucose (GLU, 0.5 g/kg) after EPI (2.5 mg/kg), both of which markedly improved mean EF (EPI 34.3% vs. EPI + INS + GLU 43.7%, P = 0.025) and significantly blunted mean hs‐TnT (EPI 14 393 pg/mL vs. EPI + INS 6864 pg/mL at 24 h, P = 0.039). Particularly, insulin additionally ameliorated myocardial pro‐inflammatory gene expression, suggesting an anti‐inflammatory effect of acute insulin therapy. Conclusions: Elevated initial plasma glucose was associated with adverse outcome‐relevant parameters in TTS and may present a surrogate parameter of heightened catecholaminergic drive. In mice, insulin‐ and glucose injection both improved EPI‐induced AHF and myocardial damage, indicating insulin resistance rather than detrimental effects of hyperglycaemia itself as the underlying cause. Future studies will investigate the role of HbA1c as a risk stratifier and of insulin‐based therapy in TTS. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

54. Temporal biomarker concentration patterns during the early course of acute coronary syndrome.

Author

Eggers, Kai M., Batra, Gorav, Lindahl, Bertil, Ghukasyan Lakic, Tatevik, Lindbäck, Johan, Budaj, Andrzej, Cornel, Jan H., Giannitsis, Evangelos, Katus, Hugo A., Storey, Robert F., Becker, Richard C., Siegbahn, Agneta, and Wallentin, Lars

Subjects
ACUTE coronary syndrome, ST elevation myocardial infarction, BIOMARKERS, MYOCARDIAL injury, C-reactive protein
Abstract

Biomarker concentrations and their changes during acute coronary syndrome (ACS) provide clinically useful information on pathophysiological processes, e.g. myocardial necrosis, hemodynamic stress and inflammation. However, current evidence on temporal biomarker patterns early during ACS is limited, and studies investigating multiple biomarkers are lacking. We measured concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and I (hs-cTnI), NT-terminal pro-B-type natriuretic peptide, C-reactive protein, and growth-differentiation factor-15 (GDF-15) in plasma samples obtained at randomization in ACS patients from the PLATelet inhibition and patient Outcomes (PLATO) trial. Linear regressions with interaction analyses were used to investigate the associations of biomarker concentrations with the time from symptom onset and to model temporal biomarker concentration patterns. The study population consisted of 16,944 patients (median age 62 years; 71.3 % males) with 6,853 (40.3 %) having ST-elevation myocardial infarction (STEMI) and 10,141 (59.7 %) having non-ST-elevation ACS (NSTE-ACS). Concentrations of all biomarkers were associated with time from symptom onset (pinteraction<0.001), apart for GDF-15 (pinteraction=0.092). Concentration increases were more pronounced in STEMI compared to NSTE-ACS. Temporal biomarker patterns for hs-cTnT and hs-cTnI were different depending on sex whereas biomarker patterns for the other biomarkers were similar in cohorts defined by age and sex. Temporal concentration patterns differ for various biomarkers early during ACS, reflecting the variability in the activation and duration of different pathophysiological processes, and the amount of injured myocardium. Our data emphasize that the time elapsed from symptom onset should be considered for the interpretation of biomarker results in ACS. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

58. Saraf-dependent activation of mTORC1 regulates cardiac growth

Author

Sanlialp, Ayse, Schumacher, Dagmar, Kiper, Leon, Varma, Eshita, Riechert, Eva, Ho, Thanh Cao, Hofmann, Christoph, Kmietczyk, Vivien, Zimmermann, Frank, Dlugosz, Sascha, Wirth, Angela, Gorska, Agnieszka A., Burghaus, Jana, Camacho Londoño, Juan E., Katus, Hugo A., Doroudgar, Shirin, Freichel, Marc, and Völkers, Mirko

Published
2020
Full Text
View/download PDF

61. Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information

Author

Amr, Ali, primary, Koelemen, Jan, additional, Reich, Christoph, additional, Sedaghat-Hamedani, Farbod, additional, Kayvanpour, Elham, additional, Haas, Jan, additional, Frese, Karen, additional, Lehmann, David, additional, Katus, Hugo A., additional, Frey, Norbert, additional, and Meder, Benjamin, additional

Published
2023
Full Text
View/download PDF

62. COVID-19 among heart transplant recipients in Germany: a multicenter survey

Author

Rivinius, Rasmus, Kaya, Ziya, Schramm, René, Boeken, Udo, Provaznik, Zdenek, Heim, Christian, Knosalla, Christoph, Schoenrath, Felix, Rieth, Andreas, Berchtold-Herz, Michael, Barten, Markus J., Rauschning, Dominic, Mücke, Victoria T., Heyl, Stephan, Pistulli, Rudin, Grinninger, Carola, Hagl, Christian, Gummert, Jan F., Warnecke, Gregor, Schulze, P. Christian, Katus, Hugo A., Kreusser, Michael M., and Raake, Philip W.

Published
2020
Full Text
View/download PDF

64. A complex intervention to promote prevention of delirium in older adults by targeting caregiver’s participation during and after hospital discharge – study protocol of the TRAnsport and DElirium in older people (TRADE) project

Author

Leinert, Christoph, Brefka, Simone, Braisch, Ulrike, Denninger, Natascha, Mueller, Martin, Benzinger, Petra, Bauer, Juergen, Bahrmann, Anke, Frey, Norbert, Katus, Hugo A., Geisler, Tobias, Eschweiler, Gerhard, Klaus, Jochen, Seufferlein, Thomas, Schuetze, Konrad, Gebhard, Florian, Dreyhaupt, Jens, Muche, Rainer, Pahmeier, Kathrin, Biermann-Stallwitz, Janine, Wasem, Juergen, Flagmeier, Lena, Dallmeier, Dhayana, and Denkinger, Michael

Published
2021
Full Text
View/download PDF

67. Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes

Author

Lugenbiel, Patrick, Govorov, Katharina, Syren, Pascal, Rahm, Ann-Kathrin, Wieder, Teresa, Wunsch, Maximilian, Weiberg, Nadine, Manolova, Emili, Gramlich, Dominik, Rivinius, Rasmus, Finke, Daniel, Lehmann, Lorenz H., Schweizer, Patrick A., Frank, Derk, El Tahry, Fadwa A., Bruehl, Claus, Heimberger, Tanja, Sandke, Steffi, Weis, Tanja, Most, Patrick, Schmack, Bastian, Ruhparwar, Arjang, Karck, Matthias, Frey, Norbert, Katus, Hugo A., and Thomas, Dierk

Published
2021
Full Text
View/download PDF

71. CAT score single item analysis in patients with COPD: Results from COSYCONET

Author

Stefan, Andreas, Robert, Bals, Jürgen, Behr, Kathrin, Kahnert, Burkhard, Bewig, Roland, Buhl, Ralf, Ewert, Beate, Stubbe, Ficker, Joachim H., Manfred, Gogol, Christian, Grohé, Rainer, Hauck, Matthias, Held, Berthold, Jany, Markus, Henke, Felix, Herth, Gerd, Höffken, Katus Hugo, A., Anne-Marie, Kirsten, Henrik, Watz, Rembert, Koczulla, Klaus, Kenn, Juliane, Kronsbein, Cornelia, Kropf-Sanchen, Christoph, Lange, Peter, Zabel, Michael, Pfeifer, Randerath Winfried, J., Werner, Seeger, Michael, Studnicka, Christian, Taube, Helmut, Teschler, Hartmut, Timmermann, Christian, Virchow J., Claus, Vogelmeier, Ulrich, Wagner, Tobias, Welte, Hubert, Wirtz, Lehnert, Doris, Struck, Birte, Krabbe, Lenka, Arikan, Barbara, Tobias, Julia, Speth, Kornelia, Pieper, Jeanette, Gleiniger, Margret, Markworth, Britta, Hinz, Zaklina, Burmann, Ellen, Wons, Katrin, Rieber, Ulrike, Schaufler, Beate, Schwedler, Katrin, Michalewski, Sabine, Rohweder, Sonja, Berger, Patricia, Schottel, Diana, Janke, Vivien, Untsch, Rosalie, Graf, Jana, Reichel, Anita, Weiß, Gertraud, Traugott, Erich, Kietzmann, Ilona, Schrade-Illmann, Michaela, Polte, Beate, Hübner, Gudrun, Marietta von Siemens, Sarah, Alter, Peter, Lutter, Johanna I., Kauczor, Hans-Ulrich, Jobst, Bertram, Bals, Robert, Trudzinski, Franziska C., Söhler, Sandra, Behr, Jürgen, Watz, Henrik, Waschki, Benjamin, Bewig, Burkhard, Jones, Paul W., Welte, Tobias, Vogelmeier, Claus F., Jörres, Rudolf A., and Kahnert, Kathrin

Published
2019
Full Text
View/download PDF

72. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Author

Mach, François, Baigent, Colin, Catapano, Alberico L., Koskinas, Konstantinos C., Casula, Manuela, Badimon, Lina, Chapman, M. John, De Backer, Guy G., Delgado, Victoria, Ference, Brian A., Graham, Ian M., Halliday, Alison, Landmesser, Ulf, Mihaylova, Borislava, Pedersen, Terje R., Riccardi, Gabriele, Richter, Dimitrios J., Sabatine, Marc S., Taskinen, Marja-Riitta, Tokgozoglu, Lale, Wiklund, Olov, Windecker, Stephan, Aboyans, Victor, Collet, Jean-Philippe, Dean, Veronica, Fitzsimons, Donna, Gale, Chris P., Grobbee, Diederick, Halvorsen, Sigrun, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo A., Leclercq, Christophe, Lettino, Maddalena, Lewis, Basil S., Merkely, Bela, Mueller, Christian, Petersen, Steffen, Petronio, Anna Sonia, Roffi, Marco, Shlyakhto, Evgeny, Simpson, Iain A., Sousa-Uva, Miguel, Touyz, Rhian M., Nibouche, Djamaleddine, Zelveian, Parounak H., Siostrzonek, Peter, Najafov, Ruslan, van de Borne, Philippe, Pojskic, Belma, Postadzhiyan, Arman, Kypris, Lambros, Špinar, Jindřich, Larsen, Mogens Lytken, Eldin, Hesham Salah, Viigimaa, Margus, Strandberg, Timo E., Ferrières, Jean, Agladze, Rusudan, Laufs, Ulrich, Rallidis, Loukianos, Bajnok, László, Gudjónsson, Thorbjörn, Maher, Vincent, Henkin, Yaakov, Gulizia, Michele Massimo, Mussagaliyeva, Aisulu, Bajraktari, Gani, Kerimkulova, Alina, Latkovskis, Gustavs, Hamoui, Omar, Slapikas, Rimvydas, Visser, Laurent, Dingli, Philip, Ivanov, Victoria, Boskovic, Aneta, Nazzi, Mbarek, Visseren, Frank, Mitevska, Irena, Retterstøl, Kjetil, Jankowski, Piotr, Fontes-Carvalho, Ricardo, Gaita, Dan, Ezhov, Marat, Foscoli, Marina, Giga, Vojislav, Pella, Daniel, Fras, Zlatko, Perez de Isla, Leopoldo, Hagström, Emil, Lehmann, Roger, Abid, Leila, Ozdogan, Oner, Mitchenko, Olena, and Patel, Riyaz S.

Published
2019
Full Text
View/download PDF

81. The lipid-droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4

Author

Jebessa, Zegeye H., Shanmukha, Kumar D., Dewenter, Matthias, Lehmann, Lorenz H., Xu, Chang, Schreiter, Friederike, Siede, Dominik, Gong, Xue-Min, Worst, Barbara C., Federico, Giuseppina, Sauer, Sven W., Fischer, Tamas, Wechselberger, Lisa, Müller, Oliver J., Sossalla, Samuel, Dieterich, Christoph, Most, Patrick, Gröne, Herrmann-Josef, Moro, Cedric, Oberer, Monika, Haemmerle, Guenter, Katus, Hugo A., Tyedmers, Jens, and Backs, Johannes

Published
2019
Full Text
View/download PDF

84. Atrial Fibrillation

Author

Rahm, Ann-Kathrin, Katus, Hugo A., Thomas, Dierk, Hecker, Markus, Editor-in-Chief, Backs, Johannes, Series Editor, Freichel, Marc, Series Editor, Korff, Thomas, Series Editor, Thomas, Dierk, Series Editor, and Remme, Carol Ann, editor

Published
2018
Full Text
View/download PDF

88. Identification and regulation of the long non-coding RNA Heat2 in heart failure

Author

Boeckel, Jes-Niels, Perret, Maya F., Glaser, Simone F., Seeger, Timon, Heumüller, Andreas W., Chen, Wei, John, David, Kokot, Karoline E., Katus, Hugo A., Haas, Jan, Lackner, Maximilian K., Kayvanpour, Elham, Grabe, Niels, Dieterich, Christoph, von Haehling, Stephan, Ebner, Nicole, Hünecke, Sabine, Leuschner, Florian, Fichtlscherer, Stephan, Meder, Benjamin, Zeiher, Andreas M., Dimmeler, Stefanie, and Keller, Till

Published
2019
Full Text
View/download PDF

91. Acute changes in cardiac dimensions, function, and longitudinal mechanics in healthy individuals with and without high‐altitude induced pulmonary hypertension at 4559 m.

Author

Mereles, Derliz, Rudolph, Jens, Greiner, Sebastian, Aurich, Matthias, Frey, Norbert, Katus, Hugo A., Bärtsch, Peter, and Dehnert, Christoph

Subjects
ECHOCARDIOGRAPHY, BLOOD pressure, LEFT heart ventricle, PULMONARY hypertension, PULMONARY artery, GLOBAL longitudinal strain, MOUNTAIN sickness, COMPARATIVE studies, DOPPLER echocardiography, CARDIAC output, RESEARCH funding, HEART physiology, HYPOXEMIA, PHENOTYPES
Abstract

Background: High‐altitude pulmonary hypertension (HAPH) has a prevalence of approximately 10%. Changes in cardiac morphology and function at high altitude, compared to a population that does not develop HAPH are scarce. Methods: Four hundred twenty‐one subjects were screened in a hypoxic chamber inspiring a FiO2 = 12% for 2 h. In 33 subjects an exaggerated increase in systolic pulmonary artery pressure (sPAP) could be confirmed in two independent measurements. Twenty nine of these, and further 24 matched subjects without sPAP increase were examined at 4559 m by Doppler echocardiography including global longitudinal strain (GLS). Results: SPAP increase was higher in HAPH subjects (∆ = 10.2 vs. ∆ = 32.0 mm Hg, p <.001). LV eccentricity index (∆ =.15 vs. ∆ =.31, p =.009) increased more in HAPH. D‐shaped LV (0 [0%] vs. 30 [93.8%], p =.00001) could be observed only in the HAPH group, and only in those with a sPAP ≥50 mm Hg. LV‐EF (∆ = 4.5 vs. ∆ = 6.7%, p =.24) increased in both groups. LV‐GLS (∆ = 1.2 vs. ∆ = 1.1 –%, p =.60) increased slightly. RV end‐diastolic (∆ = 2.20 vs. ∆ = 2.7 cm2, p =.36) and end‐systolic area (∆ = 2.1 vs. ∆ = 2.7 cm2, p =.39), as well as RA end‐systolic area index (∆ = −.9 vs. ∆ =.3 cm2/m2, p =.01) increased, RV‐FAC (∆ = −2.9 vs. ∆ = −4.7%, p =.43) decreased, this was more pronounced in HAPH, RV‐GLS (∆ = 1.6 vs. ∆ = −.7 –%, p =.17) showed marginal changes. Conclusions: LV and LA dimensions decrease and left ventricular function increases at high‐altitude in subjects with and without HAPH. RV and RA dimensions increase, and RV longitudinal strain increases or remains unchanged in subjects with HAPH. Changes are negligible in those without HAPH. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

92. Cardiological parameters predict mortality and cardiotoxicity in oncological patients.

Author

Romann, Sebastian W., Finke, Daniel, Heckmann, Markus B., Hund, Hauke, Giannitsis, Evangelos, Katus, Hugo A., Frey, Norbert, and Lehmann, Lorenz H.

Subjects
BRAIN natriuretic factor, CANCER patients, CARDIOTOXICITY, CARDIOVASCULAR diseases risk factors, VENTRICULAR ejection fraction
Abstract

Aims: Oncological patients suspected at risk for cardiotoxicity are recommended to undergo intensified cardiological surveillance. We investigated the value of cardiac biomarkers and patient‐related risk factors [age, cardiovascular risk factors (CVRFs), and cardiac function] for the prediction of all‐cause mortality (ACM) and the development of cardiotoxicity. Methods and results: Between January 2016 and December 2020, patients with oncological diseases admitted to the Cardio‐Oncology Unit at the Heidelberg University Hospital were included. They were evaluated by medical history, physical examination, 12‐lead electrocardiogram, 2D echocardiography, and cardiac biomarkers [high‐sensitivity cardiac troponin T (hs‐cTnT) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP)]. The primary endpoint was defined as ACM and the secondary endpoint was defined as cardiotoxicity, as defined by the European Society of Cardiology. Of the 1971 patients enrolled, the primary endpoint was reached by 490 patients (25.7%) with a median of 363.5 [interquartile range (IQR) 121.8, 522.5] days after presentation. Hs‐cTnT of ≥ 7 ng/L [odds ratio (OR) 1.82, P < 0.001] and NT‐proBNP (OR 1.98, P < 0.001) were independent predictors of ACM, while reduced left ventricular ejection fraction was not associated with increased ACM (P = 0.85). The secondary endpoint was reached by 182 patients (9.2%) with a median of 793.5 [IQR 411.2, 1165.0] days. Patients with multiple CVRFs (defined as high risk, n = 886) had an increased risk of cardiotoxicity (n = 100/886, 11.3%; hazard ratio 1.57, P = 0.004). They showed elevated baseline values of hs‐cTnT (OR 1.60, P = 0.006) and NT‐proBNP (OR 4.00, P < 0.001) and had an increased risk of ACM (OR 1.43, P = 0.031). Conclusions: In cancer patients, CVRF accumulation predicts cardiotoxicity whereas elevated hs‐cTnT or NT‐proBNP levels are associated with ACM. Accordingly, less intensive surveillance protocols may be warranted in patients with low cardiac biomarker levels and absence of CVRFs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

94. Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes

Author

Georgiopoulos, Georgios, primary, Kraler, Simon, additional, Mueller-Hennessen, Matthias, additional, Delialis, Dimitrios, additional, Mavraganis, Georgios, additional, Sopova, Kateryna, additional, Wenzl, Florian A., additional, Räber, Lorenz, additional, Biener, Moritz, additional, Stähli, Barbara E., additional, Maneta, Eleni, additional, Spray, Luke, additional, Iglesias, Juan F., additional, Coelho-Lima, Jose, additional, Tual-Chalot, Simon, additional, Muller, Olivier, additional, Mach, François, additional, Frey, Norbert, additional, Duerschmied, Daniel, additional, Langer, Harald F., additional, Katus, Hugo, additional, Roffi, Marco, additional, Camici, Giovanni G., additional, Mueller, Christian, additional, Giannitsis, Evangelos, additional, Spyridopoulos, Ioakim, additional, Lüscher, Thomas F., additional, Stellos, Konstantinos, additional, and Stamatelopoulos, Kimon, additional

Published
2023
Full Text
View/download PDF

95. Abstract P3040: Development Of A Protein Synthesis Network At The Sarcoplasmic Reticulum In Adult Cardiomyocytes

Author

Hofmann, Christoph, primary, Brandenburg, Sören, additional, Uhlenkamp, Dennis, additional, Meyer, Bianca, additional, Sandmann, Clara, additional, Herzog, Nicole, additional, Groß, Julia, additional, Sramek, Viviana, additional, Renz, Marc, additional, Katus, Hugo A, additional, Lehnart, Stephan E, additional, Völkers, Mirko, additional, and Doroudgar, Shirin, additional

Published
2023
Full Text
View/download PDF

96. Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy

Author

Aurich, Matthias, primary, Bucur, Julian, additional, Vey, Johannes A, additional, Greiner, Sebastian, additional, aus dem Siepen, Fabian, additional, Hegenbart, Ute, additional, Schönland, Stefan, additional, Katus, Hugo A, additional, Frey, Norbert, additional, and Mereles, Derliz, additional

Published
2023
Full Text
View/download PDF

97. Long-Term Prognosis of Patients With Takotsubo Syndrome

Author

Ghadri, Jelena R., Kato, Ken, Cammann, Victoria L., Gili, Sebastiano, Jurisic, Stjepan, Di Vece, Davide, Candreva, Alessandro, Ding, Katharina J., Micek, Jozef, Szawan, Konrad A., Bacchi, Beatrice, Bianchi, Rahel, Levinson, Rena A., Wischnewsky, Manfred, Seifert, Burkhardt, Schlossbauer, Susanne A., Citro, Rodolfo, Bossone, Eduardo, Münzel, Thomas, Knorr, Maike, Heiner, Susanne, D’Ascenzo, Fabrizio, Franke, Jennifer, Sarcon, Annahita, Napp, L. Christian, Jaguszewski, Milosz, Noutsias, Michel, Katus, Hugo A., Burgdorf, Christof, Schunkert, Heribert, Thiele, Holger, Bauersachs, Johann, Tschöpe, Carsten, Pieske, Burkert M., Rajan, Lawrence, Michels, Guido, Pfister, Roman, Cuneo, Alessandro, Jacobshagen, Claudius, Hasenfuß, Gerd, Karakas, Mahir, Koenig, Wolfgang, Rottbauer, Wolfgang, Said, Samir M., Braun-Dullaeus, Ruediger C., Banning, Adrian, Cuculi, Florim, Kobza, Richard, Fischer, Thomas A., Vasankari, Tuija, Airaksinen, K.E. Juhani, Opolski, Grzegorz, Dworakowski, Rafal, MacCarthy, Philip, Kaiser, Christoph, Osswald, Stefan, Galiuto, Leonarda, Crea, Filippo, Dichtl, Wolfgang, Empen, Klaus, Felix, Stephan B., Delmas, Clément, Lairez, Olivier, El-Battrawy, Ibrahim, Akin, Ibrahim, Borggrefe, Martin, Horowitz, John, Kozel, Martin, Tousek, Petr, Widimský, Petr, Gilyarova, Ekaterina, Shilova, Alexandra, Gilyarov, Mikhail, Winchester, David E., Ukena, Christian, Bax, Jeroen J., Prasad, Abhiram, Böhm, Michael, Lüscher, Thomas F., Ruschitzka, Frank, and Templin, Christian

Published
2018
Full Text
View/download PDF

100. Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

Author

Aboyans, Victor, Ricco, Jean-Baptiste, Bartelink, Marie-Louise E.L., Björck, Martin, Brodmann, Marianne, Cohnert, Tina, Collet, Jean-Philippe, Czerny, Martin, De Carlo, Marco, Debus, Sebastian, Espinola-Klein, Christine, Kahan, Thomas, Kownator, Serge, Mazzolai, Lucia, Naylor, A. Ross, Roffi, Marco, Röther, Joachim, Sprynger, Muriel, Tendera, Michal, Tepe, Gunnar, Venermo, Maarit, Vlachopoulos, Charalambos, Desormais, Ileana, Document Reviewers, Widimsky, Petr, Kolh, Philippe, Agewall, Stefan, Bueno, Héctor, Coca, Antonio, De Borst, Gert J., Delgado, Victoria, Dick, Florian, Erol, Cetin, Ferrini, Marc, Kakkos, Stavros, Katus, Hugo A., Knuuti, Juhani, Lindholt, Jes, Mattle, Heinrich, Pieniazek, Piotr, Piepoli, Massimo Francesco, Scheinert, Dierk, Sievert, Horst, Simpson, Iain, Sulzenko, Jakub, Tamargo, Juan, Tokgozoglu, Lale, Torbicki, Adam, Tsakountakis, Nikolaos, Tuñón, José, Vega de Ceniga, Melina, Windecker, Stephan, and Zamorano, Jose Luis

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results